This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Sep;54(3):515-8.

doi: 10.1038/bjc.1986.206.

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

M Grandi, C Geroni, F C Giuliani

PMID: 3756087
PMCID: PMC2001636
DOI: 10.1038/bjc.1986.206

Free PMC article

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

M Grandi et al. Br J Cancer. 1986 Sep.

Free PMC article

. 1986 Sep;54(3):515-8.

doi: 10.1038/bjc.1986.206.

Authors

M Grandi, C Geroni, F C Giuliani

PMID: 3756087
PMCID: PMC2001636
DOI: 10.1038/bjc.1986.206

No abstract available

PubMed Disclaimer

Similar articles

Pharmacological studies of 3'-(4-morpholinyl)-3'-deaminodaunorubicin in human colon carcinoma cells in vitro.
Johnston JB, Glazer RI. Johnston JB, et al. Cancer Res. 1983 Mar;43(3):1044-8. Cancer Res. 1983. PMID: 6186367 No abstract available.
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells.
Mungo E, Bergandi L, Salaroglio IC, Doublier S. Mungo E, et al. Int J Mol Sci. 2018 Nov 10;19(11):3550. doi: 10.3390/ijms19113550. Int J Mol Sci. 2018. PMID: 30423827 Free PMC article.
Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).
Meschini S, Condello M, Lista P, Vincenzi B, Baldi A, Citro G, Arancia G, Spugnini EP. Meschini S, et al. Eur J Cancer. 2012 Sep;48(14):2236-43. doi: 10.1016/j.ejca.2011.11.031. Epub 2012 Jan 11. Eur J Cancer. 2012. PMID: 22240284
[The selective toxicity of 5-hydroxymethyldeoxyuridine for the cells of human adenocarcinoma of the large intestine].
Lockshin A, Meshcherikova VV. Lockshin A, et al. Vopr Onkol. 1989;35(11):1327-32. Vopr Onkol. 1989. PMID: 2609523 Russian.
A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P. Bartolini G, et al. In Vivo. 2006 Nov-Dec;20(6A):729-33. In Vivo. 2006. PMID: 17203756

See all similar articles

Cited by

TMPE Derived from Saffron Natural Monoterpene as Cytotoxic and Multidrug Resistance Reversing Agent in Colon Cancer Cells.
Środa-Pomianek K, Palko-Łabuz A, Poła A, Ferens-Sieczkowska M, Wesołowska O, Kozioł A. Środa-Pomianek K, et al. Int J Mol Sci. 2020 Oct 13;21(20):7529. doi: 10.3390/ijms21207529. Int J Mol Sci. 2020. PMID: 33065997 Free PMC article.
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
Pezzoni G, Grandi M, Biasoli G, Capolongo L, Ballinari D, Giuliani FC, Barbieri B, Pastori A, Pesenti E, Mongelli N, et al. Pezzoni G, et al. Br J Cancer. 1991 Dec;64(6):1047-50. doi: 10.1038/bjc.1991.463. Br J Cancer. 1991. PMID: 1764367 Free PMC article.
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
Ripamonti M, Pezzoni G, Pesenti E, Pastori A, Farao M, Bargiotti A, Suarato A, Spreafico F, Grandi M. Ripamonti M, et al. Br J Cancer. 1992 May;65(5):703-7. doi: 10.1038/bjc.1992.148. Br J Cancer. 1992. PMID: 1586598 Free PMC article.
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
Capolongo L, Melegaro G, Broggini M, Mongelli N, Grandi M. Capolongo L, et al. Br J Cancer. 1993 Nov;68(5):916-9. doi: 10.1038/bjc.1993.454. Br J Cancer. 1993. PMID: 8105866 Free PMC article.
Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.
Misiak M, Heldt M, Szeligowska M, Mazzini S, Scaglioni L, Grabe GJ, Serocki M, Lica J, Switalska M, Wietrzyk J, Beretta GL, Perego P, Zietkowski D, Baginski M, Borowski E, Skladanowski A. Misiak M, et al. Oncotarget. 2017 Oct 10;8(62):105137-105154. doi: 10.18632/oncotarget.21806. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285240 Free PMC article.

See all "Cited by" articles

References

1. Cancer Res. 1976 Feb;36(2 Pt 1):467-75 - PubMed
1. Br J Cancer. 1986 Jan;53(1):129-35 - PubMed
1. Cancer Treat Rep. 1983 Oct;67(10):883-8 - PubMed
1. Cancer Treat Rep. 1984 Jan;68(1):87-99 - PubMed
1. Br J Cancer. 1984 Feb;49(2):247-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database